Ovarian Cancer pp 577-581 | Cite as

Phosphotyrosine Kinase Assays as a Prescreen for Inhibitors of EGFr

  • Joanne Edwards
  • John M. S. Bartlett
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 39)

Abstract

The epidermal growth factor receptor (EGFr) is a 170-kDa glycosylated transmembrane protein found in a wide variety of tissues (1). It is the receptor for epidermal growth factor (EGF), transforming growth factor α (TGFα), and other related growth factor peptides (2,3). In 1980, EGF binding activity of receptor preparations was shown to be associated with a protein kinase activity. Subsequent studies demonstrated that the EGF binding activity and kinase activity were properties of the same protein (4). In the absence of EGF, tyrosine kinase activity is low. Binding of EGF to the receptor domain results in receptor dimerisation and subsequent autophosphorylation of the cytoplasmic domain of EGFr at specific tyrosine residues. This autophosphorylation results in an activation of the tyrosine kinase activity of the EGFr. The phosphorylated tyrosine residues of the EGFr are involved in binding enzymes containing SH2 or SH3 domains (5). Enzymes identified to date that bind tightly to EGFr phosphotyrosine residues include phosphatidyl inositol 3 kinase, phospholipase Cγ and ras GTPase activating protein (6). Binding of these enzymes occurs at highly specific phosphotyrosine residues of the receptor and is believed to be a mechanism for signal transduction from the receptor to the final intracellular target.

Keywords

Phosphorus Magnesium DMSO Tyrosine Adenosine 

References

  1. 1.
    Gill, G. N., Santon, J. B., and Bertics, P. J. (1987) Regulatory features of the epidermal growth factor receptor. J. Cell. Physiol. 5, 35–41.CrossRefGoogle Scholar
  2. 2.
    Laurence, D. J. R. and Gusterson, B. A. (1990) The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumor Biol. 11, 229–261.CrossRefGoogle Scholar
  3. 3.
    Johnson, G. R., Kannan, B., Shoyab, M., and Stomberg, K. (1993) Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erb B2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. J. Biol. Chem. 268, 2924–2931.PubMedGoogle Scholar
  4. 4.
    Basu, A., Raghunath, M., Bishaylee, S., and Das, M. (1989) Inhibition of tyrosine kinase activity of the epidermal growth factor receptor by a truncated receptor form. Mol. Cell. Biol. 9, 671–677.PubMedGoogle Scholar
  5. 5.
    Pronk, G., De Vries-Smits, A., Bunday, L., Downward, J., Maassen, J., Medema, R., and Bos, J. (1994) Involvement of Shc in insulin and epidermal growth factor induced activation of p21 ras. Mol. Cell. Biol. 14, 1575–1580.PubMedGoogle Scholar
  6. 6.
    Downward, J., Yarden, Y., Mayes, E., Scrace, G., Torry, N., Stockwell, P., et al. (1984) Close similarity of epidermal growth factor receptor and v-erb B oncogene protein sequences. Nature 307, 521–527.CrossRefPubMedGoogle Scholar
  7. 7.
    Bartlett, J. M. S., Langdon, S. P., Simpson, B. J. B., Stewart, M., Katsaros, D., Sismondi, P., et al. (1996) The prognostic value of epidermal growth factor receptor mRNA expression in primary ova-rian cancer. Br. J. Cancer 73, 301–306.CrossRefPubMedGoogle Scholar
  8. 8.
    Battaglia, F., Scambia, G., Benedetti Panici, P. I., Baiocchi, G., Peronne, I., Iacobelli, S., et al. (1989) Epidermal growth factor expression in gynaecological malignancies. Gynecol. Obstet. Invest. 37, 855–862.Google Scholar
  9. 9.
    Berchuck, A., Rodriguex, G. C., Kamel, A., Dodge, R. K., Soper, J. T., Clarke-Pearson, D. L., et al. (1991) Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. I. correlation of receptor expression with prognostic factors in patents with ovarian cancer. Am. J. Obstet. Gynecol. 164, 669–674.PubMedGoogle Scholar
  10. 10.
    Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of proteins utilising the principle of protein-dye binding. Anal. Biochem. 72, 248–254.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  • Joanne Edwards
    • 1
  • John M. S. Bartlett
    • 2
  1. 1.University Department of SurgeryGlasgowScotland
  2. 2.Department of SurgeryGlasgow Royal InfirmaryGlasgowUK

Personalised recommendations